Home LiteratureArticle Details
PMID: 8317912 Published · ppublish English Journal Article

Mast cells in breast cancer.

Anticancer research ·Vol. 13 ·No. 3 ·1993-00-00 ·Pages 785-8

Aaltomaa S, Lipponen P, Papinaho S, Kosma VM

Abstract

The number of stromal mast cells was counted in 187 breast carcinomas. The number of mast cells/mm2 of tumour stroma was studied in relation to clinical, histological and quantitative prognostic factors and survival. A high number of mast cells in tumour stroma was significantly related to low S phase fraction (p = 0.001), DNA diploidy (p = 0.028), high proportion of intraductal growth (p = 0.003) and high degree of tubule formation (p = 0.044). Large tumours showed a lower number of mast cells in stroma (p = 0.08). A non-significant trend was found between mast cell count and axillary lymph node status, sex steroid receptor content, histological type, morphometric nuclear factors and mitotic frequency. In survival analysis a high mast cell count (over 10 g per mm2 of tumour stroma) was related to a favorable prognosis (p = 0.04). The present results confirm previous results in that changes in mast cell count are related to histopathological characteristics and clinical outcome in breast cancer.

MeSH Terms
Adult Aged Aged, 80 and over Breast Neoplasms/mortality,pathology Cell Count Female Humans Mast Cells/pathology Middle Aged Prognosis Survival Analysis
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Aaltomaa S
Department of Surgery, University of Kuopio, Finland.
Lipponen P
Papinaho S
Kosma V M
Article Info
Journal
Anticancer research
Abbr.
Anticancer Res
ISSN
0250-7005
Published
1993-00-00
Pages
785-8
Language
English
Region
Greece
NLM ID
8102988
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com